Rate of preterm births in pregnant women with common lower genital tract infection: A population-based study based on the clinical practice

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 5, 2009, Pages 410-418

  Bnhidy, Ferenc ^a   Cs, Nndor ^a   Puho, Erzsbet H ^b   Czeizel, Andrew E ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Antimicrobial treatment; Lower genital tract infection; Pregnancy; Preterm birth; Vulvovaginitis bacterial vaginosis

Indexed keywords

AMPICILLIN; CLOTRIMAZOLE; COTRIMOXAZOLE; METRONIDAZOLE; NITROFURANTOIN; ANTIINFECTIVE AGENT;

ADULT; ANEMIA; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMINENT ABORTION; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD; NAUSEA AND VOMITING; NEWBORN; OLIGOHYDRAMNIOS; PLACENTA DISORDER; POPULATION BASED CASE CONTROL STUDY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VULVOVAGINITIS; ADOLESCENT; CASE CONTROL STUDY; HUNGARY; POPULATION; PREGNANCY; PREGNANCY COMPLICATION; VAGINITIS;

ADOLESCENT; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOTRIMAZOLE; FEMALE; HUMANS; HUNGARY; INFANT, NEWBORN; POPULATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; RETROSPECTIVE STUDIES; VAGINOSIS, BACTERIAL; VULVOVAGINITIS; YOUNG ADULT;

EID: 69149096245     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050902801645     Document Type: Article

References (54)

1. Bjerkedahl T, Czeizel AE, Hosmer DW. Birth weight of single livebirths and weight specific early neonatal mortality in Hungary and Norway. Paediat Perinat Epidemiol 1983;3: 29-40.
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;271:75-84.
3. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 271:261-269.
4. Yarberry-Allen P, Ledger WJ, Milstein SJ. Infections of the female genital tract. In: Roberts RB, editor. Infectious diseases: Pathogenesis, diagnosis and therapy. Chicago, IL: Year Book Medical Publications; 1986.
5. McGregor JA, French JI, Richter R, Franco-Buff A, Johnson A, Hillier S, Judson FN, Todo JK. Antenatal microbiological maternal risk factors associated with prematurity. Am J Obstet Gynecol 1990;163:1465-1473.
6. Divers MJ, Lilford RJ. Infection and preterm labour: A metaanalysis. Contemp Rev Obstet Gynaecol 1993;5:71-84.
7. Chin BM, Lamon RF. The microbiology of preterm labor and delivery. Contemp Rev Obstet Gynaecol 1997;9:285-296.
8. Menon R, Fortunate SJ. Infection and the role of inflammation in preterm premature rupture of the membrane. Best Pract Res Clin Obstet Gynaecol 2007;21:467-478.
9. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:375-390.
10. Romero R, Espinoza J, Kusanovic J, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. Br J Obstet Gynaecol 2006;113:17-42.
11. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm birth. N Engl J Med 2000;342: 1500-1507.
12. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001;63:176-185.
13. Czeizel AE. First 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997;55:299-305.
14. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety 2003;12:409-416.
15. Donders GGG. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 2007;21: 355-373.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standard method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
17. Sonnex C. The amine test: A simple, rapid, inexpensive method for diagnosing bacterial vaginosis. Br J Obstet Gynaecol 1995;102:160-161.
18. Á cs N, Bánhidy F, Puhó E, Czeizel AE. No association between maternal recurrent genital herpes in pregnancy and higher risk for congenital abnormalities. Acta Obstet Gynecol Scand 2008;87:292-299.
19. Czeizel AE, Petik D, Puho E. Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Cent Eur J Publ Health 2004;12: 179-183.
20. Czeizel AE. Ten years' experience in periconception care. Eur J Obstet Gynecol Reprod Biol 1999;84:43-49.
21. Á cs F, Bánhidy F, Puho HE, Czeizel AE. No association between vulvovaginitis-bacterial vaginosis and related drug treatments of pregnant women and congenital abnormalities in their offspring. A population-based case-controls study. Cent Eur J Med 2008;3:332-340.
22. Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, Jouppila P. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000;107:1427-1432.
23. Rosenstein IJ, Morgan DJ, Sheelan Dore CJ, Lamont RT, Taylor-Robinson D. Effect of vaginally applied clindamycin on the outcome of pregnancy and on vaginal microbial flora in women. Infect Dis Obstet Gynecol 2000;8:158-165.
24. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and perinatal infections in asymptomatic women with bacterial vaginosis. A randomized, controlled trial. Obstet Gynecol 2001;97:643-648.
25. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: A randomised controlled trial. Lancet 2003;361:983-988.
26. Ugwumadu A. Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. Best Pract Res Clin Obstet Gynaecol 2007;21:391-402.
27. Bánhidy F, Ács N, Puho HE, Czeizel AE. Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatment. Scan J Infect Dis 2007;39:390-397.
28. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-167.
29. Czeizel AE, Rockenbauer M. A lower rate of preterm birth after clotrimazole therapy during pregnancy. Paediatr Perinat Epidemiol 1999;13:58-64.
30. Czeizel AE, Fladung B, Vargha P. Preterm birth reduction after clotrimazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004;114:157-163.
31. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004; 329:371-374.
32. Teichmann AT, Steigerwald U. Infektionen in Gynekologie und Geburtshilfe. Stuttgart: Wissenschaftliche Verlagsgeselschaft; 1994.
33. Engelmann E. In: Hahn H, Falke D, Kaufmann SHE, Ullmann U, editors. Medizinische mikrobiologie und infektologie. Berlin: Springer; 1999. p. 693.
34. Kazy Z, Puhó EH, Czeizel AE. The possible preterm birth preventive effect of ampicillin during pregnancy. Arch Gynecol Obstet 2006;274:215-221.
35. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal diseases with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314: 1665-1669.
36. Amon E, Lewis SV, Sibai BM, Villar MA, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: A prospective randomised study. Am J Obstet Gynecol 1988;159:539-543. (Pubitemid 18237159)
37. Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of the membranes: A randomised study. Obstet Gynecol 1989;73:721-726.
38. Pfeifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: Role of Hemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978;298:1429-1434.
39. Malouf M, Fortier J, Morin F, Dube JL. Treatment of Hemophilus vaginalis vaginitis.Obstet Gynecol 1982;57: 711-714.
40. Eschenbach DA, Critchlow CW, Watkins M, Smith K, Spiegel CA, Chen KC, Holmes KK. A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis 1983;40:73-80.
41. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, et al. Metronidazole to prevent delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000; 343:534-540.
42. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-347.
43. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104:1391-1393.
44. Hay Ph, Czeizel AE. Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:403-409.
45. Karkut G. Wirkung einer Lactobazillus-Immuntherapie auf die Genitalinfektion der Frau (Solcotrichovac/Gynatren) Geburtsch Frauenheilk 1984;44:311-314.
46. Lázár E. Varga GY, Institoris L, Ujhelyi K. Examination of factors affecting premature delivery in Kazincbarcika, with special regard to lactobacillus vaccination (Hungarian with English abstract). Magyar Noorvosok Lapja 1988;51: 353-356.
47. Czeizel AE, Puhó E, Kazy Z. The use of data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities for the evaluation of birth outcomes beyond congenital abnormalities. Cent Eur J Publ Health 2007;15:147-153.
48. Brucklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000;(2):CD000262.
49. Leitich H, Brunbauer M, Bodner-Adler B, Kaider A, Egarter C, Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: A meta-analysis. Am J Obstet Gynecol 2003;188:752-758. (Pubitemid 36332446)
50. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labour: The ORACLE II. Randomized trial. ORACLE Collaborative Group. Lancet 2001;357:989-994.
51. Romero R, Chaiworaponga T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: A role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004; 190:1509-1519.
52. Genc MR, Schantz-Dunn J. The role of gene-environment interaction in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:491-504.
53. Lamont RF. Can antibiotics prevent preterm birth - the pro and con debate. Br J Obstet Gynecol 2005;112(Suppl. 1): 67-73.
54. American College of Obstetricians and Gynecologists: Assessment of risk factors for preterm birth. ACOG Practice Bull 2001;31.